GSK2212836
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2212836, covering 2017-06-22 to 2017-06-22. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. [Phase 1]